Independent information. England-wide.Public data. Clear sources.
comparelocalcareMake a more informed choice.

RESEARCH IN ENGLAND

Explore clinical trials with England locations

Search 2,970 registered studies with identifiable England locations in our dated ClinicalTrials.gov snapshot. Explore the study and local recruitment details before contacting the research team.

Clear filters

208 matching studies · ordered by study identifier.

The area filter uses exact source postcodes. Locations without a matched postcode remain in the England-wide results.

NCT00231400 · Observational

Pompe Disease Registry Protocol

Glycogen Storage Disease Type II · Pompe Disease

Study overall: Recruiting · source record updated 23 June 2026.

9 England locations · 9 explicitly recorded as recruiting.

NCT01804686 · Interventional

A Long-term Extension Study of PCI-32765 (Ibrutinib)

Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Mantle Cell Lymphoma · Follicular Lymphoma · Diffuse Large B-cell Lymphoma · Waldenstrom Macroglobulinemia · Chronic Graft Versus Host Disease

Study overall: Recruiting · source record updated 31 July 2026.

15 England locations · 2 explicitly recorded as recruiting.

NCT03067181 · Interventional

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Childhood Extracranial Germ Cell Tumor · Extragonadal Embryonal Carcinoma · Germ Cell Tumor · Malignant Germ Cell Tumor · Malignant Ovarian Teratoma · Stage I Ovarian Choriocarcinoma · Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7 · Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7 · Stage I Testicular Choriocarcinoma AJCC v6 and v7 · Stage I Testicular Embryonal Carcinoma AJCC v6 and v7 · Stage I Testicular Seminoma AJCC v6 and v7 · Stage I Testicular Yolk Sac Tumor AJCC v6 and v7 · Stage II Ovarian Choriocarcinoma · Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7 · Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7 · Stage II Testicular Choriocarcinoma AJCC v6 and v7 · Stage II Testicular Embryonal Carcinoma AJCC v6 and v7 · Stage II Testicular Yolk Sac Tumor AJCC v6 and v7 · Stage III Ovarian Choriocarcinoma · Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7 · Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7 · Stage III Testicular Choriocarcinoma AJCC v6 and v7 · Stage III Testicular Embryonal Carcinoma AJCC v6 and v7 · Stage III Testicular Yolk Sac Tumor AJCC v6 and v7 · Stage IV Ovarian Choriocarcinoma · Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7 · Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7 · Testicular Mixed Choriocarcinoma and Embryonal Carcinoma · Testicular Mixed Choriocarcinoma and Teratoma · Testicular Mixed Choriocarcinoma and Yolk Sac Tumor

Study overall: Recruiting · source record updated 25 August 2026.

11 England locations · 10 explicitly recorded as recruiting.

NCT04064307 · Observational

Myotubular and Centronuclear Myopathy Patient Registry

Myotubular Myopathy · Myotubular Myopathy 1 · Myotubular (Centronuclear) Myopathy · Centronuclear Myopathy · Centronuclear Myopathy, X-Linked · X-linked Myotubular Myopathy

Study overall: Recruiting · source record updated 9 April 2025.

1 England locations · 1 explicitly recorded as recruiting.

More ways to explore research

This is a selected international registry feed, not every study taking place in England. NIHR also lists participation opportunities, including studies that may not appear in this selection.

NIHR Be Part of ResearchSearch the original register

Source: ClinicalTrials.gov, a United States Government database. Contains OS data © Crown copyright and database right 2026. Contains National Statistics data © Crown copyright and database right 2024; ONS country boundaries (December 2024).

Source processed: 2026-09-10 09:00:04 UTC. Retrieved: 10 September 2026. ClinicalTrials.gov terms.

How we selected and connected these records

Selected registered studies with an overall status of Recruiting or Not yet recruiting and at least one England location established by postcode, recorded nation, or source coordinates within the ONS December 2024 boundary. Retained structured fields; omitted descriptions, eligibility text, contacts and non-England locations. Deduplicated identical locations. Linked local care areas only by exact postcode geography. Location points are used for nation filtering, not directions or facility matching.